IP Library Assignment 031654/0878
Patent Assignment
Reel/Frame 031654/0878

Assignment of Assignor's Interest

Recorded: 2013-11-22 Pages: 17
Assignor
TRANSTECH PHARMA, INC.
Executed: 2013-11-14
Assignee
TRANSTECH PHARMA, LLC
4170 MENDENHALL OAKS PARKWAY, HIGH POINT, NORTH CAROLINA, 27265
Covered Properties (44)
Automated Weighing Station
Patent: 6,539,334 →
Application: 09/611,393 →
Methods to Identify Compounds That Modulate Rage
Patent: 6,908,741 →
Application: 09/799,152 →
Method for the Synthesis of Compounds of Formula I and Their Uses Thereof
Patent: 6,613,801 →
Application: 09/799,317 →
Publication: US 2002/0006957
Carboxamide Derivatives as Therapeutic Agents
Patent: 7,423,177 →
Application: 10/091,759 →
Publication: US 2002/0193432
Heteroaryl - Fused Nitrogen Heterocycles as Therapeutic Agents
Patent: 6,933,303 →
Application: 10/274,546 →
Publication: US 2004/0014778
Automated Systems for Weighing and/or Liquid Delivery
Patent: 6,898,549 →
Application: 10/332,114 →
Azole Derivatives and Fused Bicyclic Azole Derivatives as Therapeutic Agents
Patent: 7,361,678 →
Application: 10/382,203 →
Publication: US 2004/0082542
System and Method for Data Analysis, Manipulation, and Visualization
Patent: 7,146,384 →
Application: 10/411,568 →
Publication: US 2004/0010515
Aryl and Heteroaryl Compounds and Methods to Modulate Coagulation
Patent: 7,122,580 →
Application: 10/637,900 →
Publication: US 2004/0110832
Aryl and Heteroaryl Compounds, Compositions, and Methods of Use
Patent: 7,544,699 →
Application: 10/913,168 →
Publication: US 2005/0059705
Aryl and Heteroaryl Compounds, Compositions, and Methods of Use
Patent: 7,459,472 →
Application: 10/913,216 →
Publication: US 2005/0059713
Aryl and Heteroaryl Compounds, Compositions and Methods of Use
Patent: 7,501,538 →
Application: 10/913,882 →
Publication: US 2005/0049310
Methods to Identify Compounds That Modulate Rage
Patent: 7,374,891 →
Application: 11/005,843 →
Publication: US 2006/0078956
Aryl and Heteroaryl Compounds, Compositions, and Methods of Use
Patent: 7,208,601 →
Application: 11/069,521 →
Publication: US 2005/0171148
Substituted Heteroaryl Derivatives, Compositions, and Methods of Use
Patent: 7,820,704 →
Application: 11/110,499 →
Publication: US 2005/0261294
Rage Fusion Proteins
Patent: 7,901,688 →
Application: 11/197,038 →
Publication: US 2006/0030527
Benzimidazole Derivatives as Therapeutic Agents
Patent: 7,329,684 →
Application: 11/225,277 →
Publication: US 2006/0025464
N-Heteroaryl Indole Carboxamides and Analogues Thereof, for Use as Glcokinase Activators in the Treatment of Diabetes
Patent: 7,812,043 →
Application: 11/439,820 →
Publication: US 2007/0027140
Azole Derivatives and Fused Bicyclic Azole Derivatives as Therapeutic Agents
Patent: 7,714,013 →
Application: 11/511,163 →
Publication: US 2007/0021386
Rage Fusion Proteins
Patent: 7,981,423 →
Application: 11/629,437 →
Publication: US 2008/0075733
Substituted Imidazole Derivatives, Compositions, and Methods of Use as Ptpase Inhibitors
Patent: 7,723,369 →
Application: 11/699,780 →
Publication: US 2007/0191385
Benzazole Derivatives, Compositions, and Methods of Use as Aurora Kinase Inhibitors
Patent: 7,820,821 →
Application: 11/704,431 →
Publication: US 2007/0219235
Rage Fusion Proteins, Formulations, and Methods of Use Thereof
Patent: 7,981,424 →
Application: 11/789,637 →
Publication: US 2008/0045455
Heteroaromatic Glucokinase Activators
Patent: 8,148,412 →
Application: 11/791,200 →
Publication: US 2008/0139562
Azole Derivatives and Fused Bicyclic Azole Derivatives as Therapeutic Agents
Patent: 7,737,285 →
Application: 11/800,085 →
Publication: US 2007/0213347
Dicycloalkylcarbamoyl Ureas as Glucokinase Activators
Patent: 7,999,114 →
Application: 11/994,718 →
Publication: US 2008/0319028
Dicycloalkyl Urea Glucokinase Activators
Patent: 7,582,769 →
Application: 11/994,728 →
Publication: US 2009/0118501
Crystalline Forms of [3-(4- {2-Butyl- 1 -[4-(4-Chloro-Phenoxy)-Phenyl]-1H-Imidazol-4-Yl} -Phenoxy)-Propyl]-Diethyl-Amine
Patent: 7,884,219 →
Application: 12/046,872 →
Publication: US 2008/0249316
Benzamide Glucokinase Activators
Patent: 8,211,925 →
Application: 12/298,840 →
Publication: US 2010/0331379
Benzamide Glucokinase Activators
Patent: 7,880,012 →
Application: 12/298,852 →
Publication: US 2009/0176991
Oxadiazoanthracene Compounds for the Treatment of Diabetes
Patent: 7,727,983 →
Application: 12/399,504 →
Publication: US 2009/0306063
Urea Glucokinase Activators
Patent: 8,138,185 →
Application: 12/522,286 →
Publication: US 2010/0009989
Substituted Aminothiazole Derivatives, Pharmaceutical Compositions, and Methods of Use
Patent: 8,563,742 →
Application: 12/547,018 →
Publication: US 2010/0056587
Substituted Imidazole Derivatives, Compositions, and Methods of Use as Ptpase Inhibitors
Patent: 8,404,731 →
Application: 12/685,178 →
Publication: US 2010/0113331
Benzazole Derivatives, Compositions, And Methods Of Use As Aurora Kinase Inhibitors
Patent: 8,377,983 →
Application: 12/703,604 →
Publication: US 2010/0152170
Oxadiazoanthracene Compounds for the Treatment of Diabetes
Patent: 7,790,714 →
Application: 12/759,010 →
Publication: US 2010/0197677
Substituted Azoanthracene Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof
Patent: 8,383,644 →
Application: 12/825,631 →
Publication: US 2011/0160198
Oxadiazoanthracene Compounds for the Treatment of Diabetes
Patent: 7,906,507 →
Application: 12/849,225 →
Publication: US 2011/0039837
Oxadiazoanthracene Compounds for the Treatment of Diabetes
Patent: 8,524,708 →
Application: 12/872,580 →
Publication: US 2010/0324033
Substituted Imidazole Derivatives And Methods Of Use Thereof
Patent: 8,580,833 →
Application: 12/888,660 →
Publication: US 2011/0105578
N-Heteroaryl Indole Carboxamides and Analogues Thereof, for Use as Glucokinase Activators in the Treatment of Diabetes
Patent: 8,148,413 →
Application: 12/895,761 →
Publication: US 2011/0082144
Crystalline Forms of [3-(4- {2-Butyl- 1 -[4-(4-Chloro-Phenoxy)-Phenyl]-1H-Imidazol-4-Yl} -Phenoxy)-Propyl]-Diethyl-Amine
Patent: 8,372,988 →
Application: 12/982,775 →
Publication: US 2011/0166361
Phenyl-Heteroaryl Derivatives and Methods of Use Thereof
Patent: 8,431,575 →
Application: 13/028,036 →
Publication: US 2011/0230458
Nucleic Acid Molecules Encoding Rage Fusion Proteins
Patent: 8,344,120 →
Application: 13/158,748 →
Publication: US 2011/0282035
Related Assignments (12)
Other recorded transfers of the patents in this record — the chain of ownership.
Confirmation of Termination of Exclusive Patent License Jan 15, 2013
From: PFIZER, INC.
To: TRANSTECH PHARMA, INC.
Reel/Frame 029631/0111 →
Security Agreement Aug 9, 2013
From: TRANSTECH PHARMA, INC.
To: M&F TTP HOLDINGS LLC C/O MACANDREWS & FORBES HOLDINGS INC.
Reel/Frame 030982/0803 →
Notice of Release of Security Interest in Patents for Reel/Frame 030982/0803 Apr 7, 2014
From: M&F TTP HOLDINGS LLC
To: TRANSTECH PHARMA, LLC
Reel/Frame 032621/0860 →
Security Interest Feb 26, 2015
From: TRANSTECH PHARMA, LLC
To: M&F TTP HOLDINGS LLC, AS COLLATERAL AGENT
Reel/Frame 035103/0356 →
Change of Name Jun 25, 2015
From: TRANSTECH PHARMA, LLC
To: VTV THERAPEUTICS LLC
Reel/Frame 036026/0219 →
Change of Name Jul 30, 2015
From: VTV THERAPEUTICS LLC
To: VTVX HOLDINGS I LLC
Reel/Frame 036236/0165 →
Assignment of Assignor's Interest Jul 31, 2015
From: VTVX HOLDINGS I LLC
To: VTV THERAPEUTICS LLC
Reel/Frame 036242/0354 →
Release of Security Interest Aug 3, 2015
From: M&F TTP HOLDINGS LLC, AS COLLATERAL AGENT
To: VTVX HOLDINGS II LLC
Reel/Frame 036254/0780 →
Corrective Assignment to Correct the Receiving Party Data Previously Recorded at Reel: 036254 Frame: 0780. Assignor(S) Hereby Confirms the Assignment. Sep 24, 2015
From: M&F TTP HOLDINGS LLC, AS COLLATERAL AGENT
To: VTVX HOLDINGS I LLC
Reel/Frame 036675/0407 →
Security Interest Apr 18, 2018
From: VTV THERAPEUTICS LLC
To: HORIZON TECHNOLOGY FINANCE CORPORATION, AS COLLATERAL AGENT
Reel/Frame 045969/0774 →
Release of Security Interest Jan 27, 2021
From: HORIZON TECHNOLOGY FINANCE CORPORATION, AS COLLATERAL AGENT
To: VTV THERAPEUTICS LLC
Reel/Frame 055133/0214 →
Security Interest Sep 15, 2021
From: INTELLIGENT AUTOMATION, LLC
To: MADISON CAPITAL FUNDING LLC, AS COLLATERAL AGENT
Reel/Frame 057486/0906 →